Hello,
Welcome to Insider
- GSK is facing an uncertain future after stumbling with COVID-19 vaccines;
- Dental startup Tend raised $125 million despite losing 15% of its customers in 2020;
- Public health groups are worried they're losing the battle to limit alcohol takeout and delivery.
If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it...
First up this morning - The CDC and FDA have recommended immediately pausing the rollout of Johnson & Johnson's COVID-19 vaccine.
The officials cited blood clots as the concern. They noted that six women had developed the rare blood clots within six to 13 days after vaccination with J&J's single-dose
So far, more than 6.8 million J&J doses have been given to Americans>>
GlaxoSmithKline stumbled with COVID-19 shots. Now it's facing an exodus of US talent and an uncertain future as the world's vaccine leader.
- The world's largest vaccine business has been on the sidelines of the pandemic response.
GSK is facing an exodus of US vaccine scientists, with several dozen leaving in the past year.- Former GSK employees expressed frustration with the company's bureaucracy and pandemic response.
A New York dental startup had to close for 3 months and lost 15% of its business last year. It just got $125 million to fuel its comeback.
Tend , a dental startup in New York City, said Monday it raised $125 million in Series C funding.- Tend in 2020 closed its six clinics for three months at the start of the pandemic.
- CEO Doug Hudson told Insider the business has recovered to about 85% of its previous revenue since.
A battle is brewing over the industry push to make booze-to-go permanent in the US. Public-health groups fear they're losing the fight.
- More than 30 states allowed alcohol takeout and delivery during the
coronavirus pandemic. - Many states, backed by restaurants and alcohol groups, want it to become a permanent fixture.
- But public-health groups worry there will be consequences from looser alcohol regulations.
More stories we're reading:
- CDC director offered a solution to the Michigan COVID-19 surge: 'Shut things down' (Insider)
- Meet Kati Kariko, a scientist who was crucial to developing mRNA vaccines (The New York Times)
- China's Sinovac vaccine is 50.7% effective against COVID-19, just reaching the threshold to be a vaccine worth using, a major trial showed (Insider)
- Regeneron says its antibody cocktail can help prevent COVID-19 (Fierce Pharma)
- Microsoft will buy AI firm Nuance for $19.7 billion to bolster healthcare tech (Insider)
- Lydia